Back to results
US 9,809,544 B2Granted
KCNQ2-5 channel activator
AssigneeOno Pharmaceutical Co., Ltd.
InventorsKentaro Yashiro, Daisuke Wakamatsu, Tetsuji Saito
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound, 1-[(5-chloro-2-pyridinyl)methyl]-3-{2,6-dichloro-4-[(2S)-1,1,1-trifluoro-2-hydroxy-2-propanyl]phenyl}urea, or a pharmaceutically acceptable salt thereof.
Claims2
1-[(5-chloro-2-pyridinyl)methyl]-3-{2,6-dichloro-4-[(2S)-1,1,1-trifluoro-2-hydroxy-2-propanyl]phenyl}urea, or
- a pharmaceutically acceptable salt thereof.
1-[(5-chloro-2-pyridinyl)methyl]-3-{2,6-dichloro-4-[(2S)-1,1,1-trifluoro-2-hydroxy-2-propanyl]phenyl}urea.
Dependencies are inferred from the claim text.